tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
The FlyStubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
2d ago
AMT
BAP
BridgeBio initiated with a Neutral at Citi
PremiumThe Fly
BridgeBio initiated with a Neutral at Citi
3d ago
BBIO
BridgeBio Files FDA NDA for Encaleret in ADH1
PremiumCompany Announcements
BridgeBio Files FDA NDA for Encaleret in ADH1
7d ago
8K
BBIO
BridgeBio shares have ‘clear path’ to $90s, says JPMorgan
PremiumThe Fly
BridgeBio shares have ‘clear path’ to $90s, says JPMorgan
9d ago
BBIO
BridgeBio announces new data of Phase 3 ATTRibute-CM study at Heart Failure 2026
PremiumThe Fly
BridgeBio announces new data of Phase 3 ATTRibute-CM study at Heart Failure 2026
10d ago
BBIO
BridgeBio price target raised to $110 from $100 at H.C. Wainwright
PremiumThe FlyBridgeBio price target raised to $110 from $100 at H.C. Wainwright
10d ago
BBIO
BridgeBio Pharma Signals Atruvio‑Led Turnaround
Premium
Company Announcements
BridgeBio Pharma Signals Atruvio‑Led Turnaround
12d ago
BBIO
BridgeBio price target raised to $130 from $125 at Evercore ISI
Premium
The Fly
BridgeBio price target raised to $130 from $125 at Evercore ISI
13d ago
BBIO
BridgeBio price target lowered to $94 from $98 at Morgan Stanley
PremiumThe Fly
BridgeBio price target lowered to $94 from $98 at Morgan Stanley
13d ago
BBIO
BridgeBio Pharma Launches New $500 Million ATM Program
PremiumCompany Announcements
BridgeBio Pharma Launches New $500 Million ATM Program
13d ago
8K
BBIO
BridgeBio price target raised to $114 from $100 at Bernstein
PremiumThe Fly
BridgeBio price target raised to $114 from $100 at Bernstein
13d ago
BBIO
BridgeBio files automatic mixed securities shelf
PremiumThe Fly
BridgeBio files automatic mixed securities shelf
13d ago
BBIO
BridgeBio Pharma Announces $500 Million Stock Repurchase Program
PremiumCompany AnnouncementsBridgeBio Pharma Announces $500 Million Stock Repurchase Program
13d ago
8K
BBIO
BridgeBio reports Q1 EPS (84c), consensus (62c)
Premium
The Fly
BridgeBio reports Q1 EPS (84c), consensus (62c)
13d ago
BBIO
BridgeBio receives regulatory approval in Brazil for Beyonttra
Premium
The Fly
BridgeBio receives regulatory approval in Brazil for Beyonttra
14d ago
BBIO
BridgeBio price target raised to $102 from $95 at Truist
PremiumThe Fly
BridgeBio price target raised to $102 from $95 at Truist
22d ago
BBIO
Zemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang
PremiumRatings
Zemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang
22d ago
BBIO
BofA ups BridgeBio price target, cites exclusivity ‘disappointment’ for pullback
PremiumThe Fly
BofA ups BridgeBio price target, cites exclusivity ‘disappointment’ for pullback
23d ago
PFE
BBIO
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
PremiumThe Fly
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
23d ago
GM
KO
Pfizer Vyndamax settlement at lower end of expectations, says Morgan Stanley
PremiumThe FlyPfizer Vyndamax settlement at lower end of expectations, says Morgan Stanley
23d ago
PFE
BBIO
BridgeBio turns negative after Pfizer details tamidis settlement
Premium
The Fly
BridgeBio turns negative after Pfizer details tamidis settlement
23d ago
PFE
BBIO
BridgeBio jumps 12% to $83.18 as Pfizer confirms tafamidis settlement
Premium
The Fly
BridgeBio jumps 12% to $83.18 as Pfizer confirms tafamidis settlement
23d ago
PFE
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >